
|Articles|May 1, 2003
Patent covers all azalide use for ocular infections
Alameda, CA-The U.S. Patent & Trademark Office said InSite Vision Inc.'s patent gives the company sole rights to the use of azalide antibiotic formulations as a topical treatment of ocular infections.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Moorfields study reveals sharp rise in glaucoma burden across the UK
2
Why individualized glaucoma care remains essential amid uneven patient awareness
3
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
4
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
5














































